Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249077 · ClinicalTrials.gov registry record
Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 8,198
- Enrollment target
NCT03249077 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 8,198 participants.
The verdict
NCT03249077 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 8,198 participants
- Enrollment target
Study Summary
In preparation for the roll out of the Medicare Diabetes Prevention Program (DPP) in 2018, Kaiser Permanente Northwest (KPNW), a large, integrated health care system, plans to pilot the implementation of DPP starting in April 2017. Patients 19-75 years old at high risk for diabetes will be offered DPP online or DPP in-person. A pragmatic, rigorous, quantitative and qualitative evaluation will be conducted to compare patients enrolled in DPP (either online or in-person) to those not enrolled to better inform future implementation efforts of DPP within and outside of KPNW. This study is a natural experiment project.
Interventions
- BEHAVIORAL Digital DPP
- BEHAVIORAL In-person DPP
- OTHER DPP not enrolled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,198 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2021-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03249077
The ClinicalTrials.gov registry entry for NCT03249077 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8,198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Digital DPP is the first listed.
NCT03249077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03249077 about?
NCT03249077 is a clinical study titled "Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System". In preparation for the roll out of the Medicare Diabetes Prevention Program (DPP) in 2018, Kaiser Permanente Northwest (KPNW), a large, integrated health care system, plans to pilot the implementation of DPP starting in April 2017. Patients 19-75 years old at high risk for diabetes will be offered D...
What is the current status of trial NCT03249077?
This trial is currently completed. The enrollment target is 8,198 participants. The study started on 2017-07-01. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT03249077?
The interventions under investigation include: Digital DPP (BEHAVIORAL), In-person DPP (BEHAVIORAL), DPP not enrolled (OTHER).
Who is sponsoring clinical trial NCT03249077?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.